Report Detail
Global Fluoropolymer in Healthcare Supply, Demand and Key Producers, 2026-2032
- RnM4663511 |
- 19 January, 2026 |
- Global |
- 119 Pages |
- GIR |
- Medical Devices & Consumables
The global Fluoropolymer in Healthcare market size is expected to reach $ 1093 million by 2032, rising at a market growth of 4.3% CAGR during the forecast period (2026-2032).
Fluoropolymers are fluorocarbon based polymers formed by strong bonds between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics with high acid, alkali and solvent resistance. Various fluoropolymer products, such as polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polytrifluoroethylene (PCTFE), polyfluoroethylene (PVF), ethylene trifluoroethylene (ECTFE), perfluoroalkoxy (PFA), and fluoroelastomers are usually used in the medical market.
Based on geography, the Fluoropolymer In Healthcare market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regionally, North America, Europe and Asia-Pacific are the major market of fluoropolymer in medical market. Due to the contact with the liquid medicine or the human body, the basic requirements of medical plastics are chemical stability and biological safety. The components in the plastic material cannot be precipitated into the liquid or the human body, will not cause toxicity and damage to tissues and organs, and are non-toxic and harmless to the human body. In order to ensure the biosafety of medical plastics, the medical plastics usually sold in the market are certified and tested by medical authorities, and users are clearly informed which grades are medical grade. Requirement in different region are also different. For USA, Fluoropolymer medical product usually pass FDA certification and USPVI biological testing, in Europe, the fluoropolymer needs CE certification, In China, medical-grade fluoropolymer are usually tested by Shandong Medical Device Testing Center.
PTFE was the dominant product segment and accounted for Nearly 59.03% share of the overall medical Fluoropolymer compounds market in 2023. PTFE is a soft polymer widely used as the porous material in pre-sterilized single-use medical applications such as filtration membrane and material. Increasing demand for PTFE in the disposable consumables is anticipated to fuel growth over the forecast period. FEP and PFA are more often used as tubing material in Drug Delivery and Medical Devices.
The medical disposables segment was valued at over 265 Million USD in 2023. This segment accounted for a large market share in terms of demand owing to the increasing usage of sterilized and disposable consumables in the healthcare sector due to the impact of COVID-19. In pharmaceutical packaging, the demand is stalely increased as the growing need for high barrier packaging material.
Medical Devices market, PTFE has been successfully marketed by Gore in the field of wound management materials and as fibers in blood purification devices. Also, Fluoropolymer coating material for medical device provide dry lubrication, insulation, and non-stick properties. Fluoropolymer for Drug Delivery market is usually consumed as coating material due to its insulation properties.
North America is the most mature market of fluoropolymer in the worldwide. The medical grade fluoropolymer market in North America is mainly concentrated in USA, with 3M, Chemours Daikin and Gore as the main company. Market in USA has been growing at over global average level for the past several years. USP defines the criteria for testing biological reactivity and the amount/type of extractables. The hygienic fluoropolymer in service must meet USP Class VI specifications.
In North America, USA is the major market of fluoropolymer in healthcare market with sales volume market share reached to 92 % in 2023. The market growth rate in USA is higher than global average rate as well as Europe. Major supplier from USA are Chemours, Saint-Gobain, W.L.Gore & Associates., Arkema, Zeus and Donaldson. Among these suppliers, Chemours and Gore are the key supplier in this region. There is no major supplier in Canada, so Canada is the net importer of fluoropolymer in healthcare market.
For Chemours, Teflon™ PTFE and PFA tubing are major type of injection grade fluoropolymer product in North America. The product has the advantages of high temperature resistance, voltage resistance, corrosion resistance, wear resistance, good self-sliding, transparency and hardness. Extruded tubing, heat shrink tubing and multi-lumen tubing are high purity, smooth, non-toxic, non-allergic, and compatible with human tissues and fluids, so many products have been chosen by the medical industry. For example, fluoropolymer heat shrinkable tube products are widely used in the continuation of medical device delivery tubes, etc. The heat-shrinkable tube is non-toxic, lubricated surface and non-stick, preventing the sticking and removal of harmful and toxic matter.
The working temperature of PTFE heat shrinkable tube is -65-260°C, and the working temperature of FEP heat shrinkable tube is -80-200°C. It can be seen that the working temperature range of PTFE heat shrinkable tube is larger than that of FEP heat shrinkable tube. Also, PTFE heat shrink tubing has two shrink ratios 1.7:1 and 4:1, while FEP heat shrink tubing has only one shrink ratio 1.7:1. However, PTFE is opaque, which makes liquid in the tube hard to be observed. A feature of FEP-heat shrink tubing is transparency and light penetration, so FEP-heat shrink tubing is typically used in applications with low shrink temperature, greater flexibility, and higher requirements for light transmittance and lubrication. The demand for PTFE and FEP can’t be replaced by each other. Specific application of PTFE and FEP heat shrinkable connection tube are medical cotton swabs, disposable medical devices, orthopedic support frames, endoscopes, washable telescopic devices, etc.
Gore is the main company that develop the use of PTFE in medical membrane. In 1975, the first GORE-TEX® Vascular Graft is commercialized, launching Gore’s medical business. In 1981, Gore launches its first medical ePTFE patch product, the GORE-TEX® Cardiovascular Patch. In 1997, Gore introduces its first minimally-invasive endovascular prosthesis, marrying ePTFE grafts with Nitinol stents. In 2018, GORE® Improject Plunger unveiled. Provides the only option for siliconefree delivery of sensitive biologicals. Also,. Gore developed PTFE venting membrane for use of medical filtration. Some medical liquids contain entrained gas which may present a hazard to the patient or affect the proper operation of a medical device. GORE Microfiltration Media for Medical Devices is designed for high levels of gas permeability which can allow for fast pressure equalization and airflow. For instance, in IV lines, GORE Media aids in the dissipation of these gas bubbles while retaining liquids that are under pressure.
This report studies the global Fluoropolymer in Healthcare production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fluoropolymer in Healthcare and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fluoropolymer in Healthcare that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fluoropolymer in Healthcare total production and demand, 2021-2032, (MT)
Global Fluoropolymer in Healthcare total production value, 2021-2032, (USD Million)
Global Fluoropolymer in Healthcare production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Fluoropolymer in Healthcare consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Fluoropolymer in Healthcare domestic production, consumption, key domestic manufacturers and share
Global Fluoropolymer in Healthcare production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Fluoropolymer in Healthcare production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Fluoropolymer in Healthcare production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Fluoropolymer in Healthcare market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chemours, Daikin, Solvay, 3M, AGC, Saint-Gobain, W.L.Gore & Associates, Arkema, Gujarat, HaloPolymer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fluoropolymer in Healthcare market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Fluoropolymer in Healthcare Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Fluoropolymer in Healthcare Market, Segmentation by Type:
PTFE
PVDF
FEP
PFA
Others
Global Fluoropolymer in Healthcare Market, Segmentation by Application:
Medical Disposables
Pharmaceutical Packaging
Medical Devices
Drug Delivery
Others
Companies Profiled:
Chemours
Daikin
Solvay
3M
AGC
Saint-Gobain
W.L.Gore & Associates
Arkema
Gujarat
HaloPolymer
Zeus
Donaldson
Key Questions Answered:
1. How big is the global Fluoropolymer in Healthcare market?
2. What is the demand of the global Fluoropolymer in Healthcare market?
3. What is the year over year growth of the global Fluoropolymer in Healthcare market?
4. What is the production and production value of the global Fluoropolymer in Healthcare market?
5. Who are the key producers in the global Fluoropolymer in Healthcare market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Fluoropolymer in Healthcare Introduction
- 1.2 World Fluoropolymer in Healthcare Supply & Forecast
- 1.2.1 World Fluoropolymer in Healthcare Production Value (2021 & 2025 & 2032)
- 1.2.2 World Fluoropolymer in Healthcare Production (2021-2032)
- 1.2.3 World Fluoropolymer in Healthcare Pricing Trends (2021-2032)
- 1.3 World Fluoropolymer in Healthcare Production by Region (Based on Production Site)
- 1.3.1 World Fluoropolymer in Healthcare Production Value by Region (2021-2032)
- 1.3.2 World Fluoropolymer in Healthcare Production by Region (2021-2032)
- 1.3.3 World Fluoropolymer in Healthcare Average Price by Region (2021-2032)
- 1.3.4 North America Fluoropolymer in Healthcare Production (2021-2032)
- 1.3.5 Europe Fluoropolymer in Healthcare Production (2021-2032)
- 1.3.6 China Fluoropolymer in Healthcare Production (2021-2032)
- 1.3.7 Japan Fluoropolymer in Healthcare Production (2021-2032)
- 1.3.8 India Fluoropolymer in Healthcare Production (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Fluoropolymer in Healthcare Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Fluoropolymer in Healthcare Major Market Trends
2 Demand Summary
- 2.1 World Fluoropolymer in Healthcare Demand (2021-2032)
- 2.2 World Fluoropolymer in Healthcare Consumption by Region
- 2.2.1 World Fluoropolymer in Healthcare Consumption by Region (2021-2026)
- 2.2.2 World Fluoropolymer in Healthcare Consumption Forecast by Region (2027-2032)
- 2.3 United States Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.4 China Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.5 Europe Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.6 Japan Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.7 South Korea Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.8 ASEAN Fluoropolymer in Healthcare Consumption (2021-2032)
- 2.9 India Fluoropolymer in Healthcare Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
- 3.1 World Fluoropolymer in Healthcare Production Value by Manufacturer (2021-2026)
- 3.2 World Fluoropolymer in Healthcare Production by Manufacturer (2021-2026)
- 3.3 World Fluoropolymer in Healthcare Average Price by Manufacturer (2021-2026)
- 3.4 Fluoropolymer in Healthcare Company Evaluation Quadrant
- 3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Fluoropolymer in Healthcare Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Fluoropolymer in Healthcare in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Fluoropolymer in Healthcare in 2025
- 3.6 Fluoropolymer in Healthcare Market: Overall Company Footprint Analysis
- 3.6.1 Fluoropolymer in Healthcare Market: Region Footprint
- 3.6.2 Fluoropolymer in Healthcare Market: Company Product Type Footprint
- 3.6.3 Fluoropolymer in Healthcare Market: Company Product Application Footprint
- 3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
- 3.8 New Entrant and Capacity Expansion Plans
- 3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
- 4.1 United States VS China: Fluoropolymer in Healthcare Production Value Comparison
- 4.1.1 United States VS China: Fluoropolymer in Healthcare Production Value Comparison (2021 & 2025 & 2032)
- 4.1.2 United States VS China: Fluoropolymer in Healthcare Production Value Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States VS China: Fluoropolymer in Healthcare Production Comparison
- 4.2.1 United States VS China: Fluoropolymer in Healthcare Production Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Fluoropolymer in Healthcare Production Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States VS China: Fluoropolymer in Healthcare Consumption Comparison
- 4.3.1 United States VS China: Fluoropolymer in Healthcare Consumption Comparison (2021 & 2025 & 2032)
- 4.3.2 United States VS China: Fluoropolymer in Healthcare Consumption Market Share Comparison (2021 & 2025 & 2032)
- 4.4 United States Based Fluoropolymer in Healthcare Manufacturers and Market Share, 2021-2026
- 4.4.1 United States Based Fluoropolymer in Healthcare Manufacturers, Headquarters and Production Site (States, Country)
- 4.4.2 United States Based Manufacturers Fluoropolymer in Healthcare Production Value (2021-2026)
- 4.4.3 United States Based Manufacturers Fluoropolymer in Healthcare Production (2021-2026)
- 4.5 China Based Fluoropolymer in Healthcare Manufacturers and Market Share
- 4.5.1 China Based Fluoropolymer in Healthcare Manufacturers, Headquarters and Production Site (Province, Country)
- 4.5.2 China Based Manufacturers Fluoropolymer in Healthcare Production Value (2021-2026)
- 4.5.3 China Based Manufacturers Fluoropolymer in Healthcare Production (2021-2026)
- 4.6 Rest of World Based Fluoropolymer in Healthcare Manufacturers and Market Share, 2021-2026
- 4.6.1 Rest of World Based Fluoropolymer in Healthcare Manufacturers, Headquarters and Production Site (State, Country)
- 4.6.2 Rest of World Based Manufacturers Fluoropolymer in Healthcare Production Value (2021-2026)
- 4.6.3 Rest of World Based Manufacturers Fluoropolymer in Healthcare Production (2021-2026)
5 Market Analysis by Type
- 5.1 World Fluoropolymer in Healthcare Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 PTFE
- 5.2.2 PVDF
- 5.2.3 FEP
- 5.2.4 PFA
- 5.2.5 Others
- 5.3 Market Segment by Type
- 5.3.1 World Fluoropolymer in Healthcare Production by Type (2021-2032)
- 5.3.2 World Fluoropolymer in Healthcare Production Value by Type (2021-2032)
- 5.3.3 World Fluoropolymer in Healthcare Average Price by Type (2021-2032)
6 Market Analysis by Application
- 6.1 World Fluoropolymer in Healthcare Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Medical Disposables
- 6.2.2 Pharmaceutical Packaging
- 6.2.3 Medical Devices
- 6.2.4 Drug Delivery
- 6.2.5 Others
- 6.3 Market Segment by Application
- 6.3.1 World Fluoropolymer in Healthcare Production by Application (2021-2032)
- 6.3.2 World Fluoropolymer in Healthcare Production Value by Application (2021-2032)
- 6.3.3 World Fluoropolymer in Healthcare Average Price by Application (2021-2032)
7 Company Profiles
- 7.1 Chemours
- 7.1.1 Chemours Details
- 7.1.2 Chemours Major Business
- 7.1.3 Chemours Fluoropolymer in Healthcare Product and Services
- 7.1.4 Chemours Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 Chemours Recent Developments/Updates
- 7.1.6 Chemours Competitive Strengths & Weaknesses
- 7.2 Daikin
- 7.2.1 Daikin Details
- 7.2.2 Daikin Major Business
- 7.2.3 Daikin Fluoropolymer in Healthcare Product and Services
- 7.2.4 Daikin Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Daikin Recent Developments/Updates
- 7.2.6 Daikin Competitive Strengths & Weaknesses
- 7.3 Solvay
- 7.3.1 Solvay Details
- 7.3.2 Solvay Major Business
- 7.3.3 Solvay Fluoropolymer in Healthcare Product and Services
- 7.3.4 Solvay Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 Solvay Recent Developments/Updates
- 7.3.6 Solvay Competitive Strengths & Weaknesses
- 7.4 3M
- 7.4.1 3M Details
- 7.4.2 3M Major Business
- 7.4.3 3M Fluoropolymer in Healthcare Product and Services
- 7.4.4 3M Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.4.5 3M Recent Developments/Updates
- 7.4.6 3M Competitive Strengths & Weaknesses
- 7.5 AGC
- 7.5.1 AGC Details
- 7.5.2 AGC Major Business
- 7.5.3 AGC Fluoropolymer in Healthcare Product and Services
- 7.5.4 AGC Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.5.5 AGC Recent Developments/Updates
- 7.5.6 AGC Competitive Strengths & Weaknesses
- 7.6 Saint-Gobain
- 7.6.1 Saint-Gobain Details
- 7.6.2 Saint-Gobain Major Business
- 7.6.3 Saint-Gobain Fluoropolymer in Healthcare Product and Services
- 7.6.4 Saint-Gobain Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.6.5 Saint-Gobain Recent Developments/Updates
- 7.6.6 Saint-Gobain Competitive Strengths & Weaknesses
- 7.7 W.L.Gore & Associates
- 7.7.1 W.L.Gore & Associates Details
- 7.7.2 W.L.Gore & Associates Major Business
- 7.7.3 W.L.Gore & Associates Fluoropolymer in Healthcare Product and Services
- 7.7.4 W.L.Gore & Associates Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.7.5 W.L.Gore & Associates Recent Developments/Updates
- 7.7.6 W.L.Gore & Associates Competitive Strengths & Weaknesses
- 7.8 Arkema
- 7.8.1 Arkema Details
- 7.8.2 Arkema Major Business
- 7.8.3 Arkema Fluoropolymer in Healthcare Product and Services
- 7.8.4 Arkema Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.8.5 Arkema Recent Developments/Updates
- 7.8.6 Arkema Competitive Strengths & Weaknesses
- 7.9 Gujarat
- 7.9.1 Gujarat Details
- 7.9.2 Gujarat Major Business
- 7.9.3 Gujarat Fluoropolymer in Healthcare Product and Services
- 7.9.4 Gujarat Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.9.5 Gujarat Recent Developments/Updates
- 7.9.6 Gujarat Competitive Strengths & Weaknesses
- 7.10 HaloPolymer
- 7.10.1 HaloPolymer Details
- 7.10.2 HaloPolymer Major Business
- 7.10.3 HaloPolymer Fluoropolymer in Healthcare Product and Services
- 7.10.4 HaloPolymer Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.10.5 HaloPolymer Recent Developments/Updates
- 7.10.6 HaloPolymer Competitive Strengths & Weaknesses
- 7.11 Zeus
- 7.11.1 Zeus Details
- 7.11.2 Zeus Major Business
- 7.11.3 Zeus Fluoropolymer in Healthcare Product and Services
- 7.11.4 Zeus Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.11.5 Zeus Recent Developments/Updates
- 7.11.6 Zeus Competitive Strengths & Weaknesses
- 7.12 Donaldson
- 7.12.1 Donaldson Details
- 7.12.2 Donaldson Major Business
- 7.12.3 Donaldson Fluoropolymer in Healthcare Product and Services
- 7.12.4 Donaldson Fluoropolymer in Healthcare Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.12.5 Donaldson Recent Developments/Updates
- 7.12.6 Donaldson Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Fluoropolymer in Healthcare Industry Chain
- 8.2 Fluoropolymer in Healthcare Upstream Analysis
- 8.2.1 Fluoropolymer in Healthcare Core Raw Materials
- 8.2.2 Main Manufacturers of Fluoropolymer in Healthcare Core Raw Materials
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis
- 8.5 Fluoropolymer in Healthcare Production Mode
- 8.6 Fluoropolymer in Healthcare Procurement Model
- 8.7 Fluoropolymer in Healthcare Industry Sales Model and Sales Channels
- 8.7.1 Fluoropolymer in Healthcare Sales Model
- 8.7.2 Fluoropolymer in Healthcare Typical Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Fluoropolymer in Healthcare. Industry analysis & Market Report on Fluoropolymer in Healthcare is a syndicated market report, published as Global Fluoropolymer in Healthcare Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Fluoropolymer in Healthcare market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
